<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zhao P</submitter><funding>National Natural Science Foundation of China</funding><pagination>3389</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10142363</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>28(8)</volume><pubmed_abstract>Triple-negative breast cancer (TNBC) is the most aggressive molecular subtype of breast cancer. Curcumol, as a natural small molecule compound, has potential anti-breast cancer activity. In this study, we chemically synthesized a derivative of curcumol, named HCL-23, by structural modification and explored its effect on and underlying mechanism regarding TNBC progression. MTT and colony formation assays demonstrated that HCL-23 significantly inhibited TNBC cells proliferation. HCL-23 induced G2/M phase cell cycle arrest and repressed the capability of migration, invasion, and adhesion in MDA-MB-231 cells. RNA-seq results identified 990 differentially expressed genes including 366 upregulated and 624 downregulated genes. Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), an</pubmed_abstract><journal>Molecules (Basel, Switzerland)</journal><pubmed_title>A Novel Derivative of Curcumol, HCL-23, Inhibits the Malignant Phenotype of Triple-Negative Breast Cancer and Induces Apoptosis and HO-1-Dependent Ferroptosis.</pubmed_title><pmcid>PMC10142363</pmcid><funding_grant_id>82160813, 32060210, 81872772, 81960546, U1812403</funding_grant_id><pubmed_authors>Qiu J</pubmed_authors><pubmed_authors>Yang J</pubmed_authors><pubmed_authors>Pan Y</pubmed_authors><pubmed_authors>Chen M</pubmed_authors><pubmed_authors>Chen L</pubmed_authors><pubmed_authors>Hao X</pubmed_authors><pubmed_authors>Huang L</pubmed_authors><pubmed_authors>Song H</pubmed_authors><pubmed_authors>Gao F</pubmed_authors><pubmed_authors>Li Y</pubmed_authors><pubmed_authors>Pan C</pubmed_authors><pubmed_authors>Zhao P</pubmed_authors><pubmed_authors>Jin J</pubmed_authors><pubmed_authors>Tang Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>A Novel Derivative of Curcumol, HCL-23, Inhibits the Malignant Phenotype of Triple-Negative Breast Cancer and Induces Apoptosis and HO-1-Dependent Ferroptosis.</name><description>Triple-negative breast cancer (TNBC) is the most aggressive molecular subtype of breast cancer. Curcumol, as a natural small molecule compound, has potential anti-breast cancer activity. In this study, we chemically synthesized a derivative of curcumol, named HCL-23, by structural modification and explored its effect on and underlying mechanism regarding TNBC progression. MTT and colony formation assays demonstrated that HCL-23 significantly inhibited TNBC cells proliferation. HCL-23 induced G2/M phase cell cycle arrest and repressed the capability of migration, invasion, and adhesion in MDA-MB-231 cells. RNA-seq results identified 990 differentially expressed genes including 366 upregulated and 624 downregulated genes. Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), an</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Apr</publication><modification>2025-04-25T21:20:11.349Z</modification><creation>2024-12-04T10:48:54.513Z</creation></dates><accession>S-EPMC10142363</accession><cross_references><pubmed>37110625</pubmed><doi>10.3390/molecules28083389</doi></cross_references></HashMap>